November 30, 2016 - By Dolores Ford · 0 Comments
The stock of Cardiovascular Systems Incorporated (NASDAQ:CSII) registered a decrease of 4.38% in short interest. CSII’s total short interest was 1.49M shares in November as published by FINRA. Its down 4.38% from 1.56 million shares, reported previously. With 343,500 shares average volume, it will take short sellers 4 days to cover their CSII’s short positions. The short interest to Cardiovascular Systems Incorporated’s float is 5.59%. About 53,639 shares traded hands. Cardiovascular Systems Inc (NASDAQ:CSII) has risen 73.06% since April 27, 2016 and is uptrending. It has outperformed by 67.83% the S&P500.
Cardiovascular Systems, Inc. is a medical technology company. The company has a market cap of $812.27 million. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. It currently has negative earnings. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Insitutional Activity: The institutional sentiment increased to 1.77 in Q2 2016. Its up 0.45, from 1.32 in 2016Q1. The ratio is positive, as 7 funds sold all Cardiovascular Systems Inc shares owned while 30 reduced positions. 15 funds bought stakes while 34 increased positions. They now own 22.60 million shares or 20.49% more from 18.76 million shares in 2016Q1.
Schwab Charles Investment Mngmt Inc accumulated 112,589 shares or 0% of the stock. Great West Life Assurance Can last reported 0% of its portfolio in the stock. Creative Planning last reported 0% of its portfolio in the stock. Geneva Advsr accumulated 15,330 shares or 0.01% of the stock. Amer Int Gru accumulated 18,342 shares or 0% of the stock. Menta Capital Limited Liability Com has 20,021 shares for 0.05% of their US portfolio. Citigroup holds 2,922 shares or 0% of its portfolio. The United Kingdom-based Legal General Group Incorporated Public Limited Com has invested 0% in Cardiovascular Systems Inc (NASDAQ:CSII). Perkins Capital Mgmt accumulated 2.35% or 111,600 shares. Wellington Llp last reported 2.72M shares in the company. Ironwood Ltd Company has 1.19% invested in the company for 86,427 shares. Granahan Investment Mngmt Incorporated Ma owns 1.12M shares or 0.75% of their US portfolio. First Manhattan Com has 1.39 million shares for 0.16% of their US portfolio. Numeric Invsts Limited Liability Company holds 20,300 shares or 0% of its portfolio. D E Shaw & holds 0.03% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII) for 815,925 shares.
Out of 6 analysts covering Cardiovascular Systems (NASDAQ:CSII), 4 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 67% are positive. Cardiovascular Systems has been the topic of 15 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The company was downgraded on Thursday, October 8 by Needham. The company was downgraded on Friday, January 22 by Needham. Needham maintained the stock with “Strong Buy” rating in Thursday, August 6 report. The stock of Cardiovascular Systems Inc (NASDAQ:CSII) earned “Buy” rating by Needham on Thursday, November 5. Needham maintained Cardiovascular Systems Inc (NASDAQ:CSII) rating on Wednesday, June 29. Needham has “Buy” rating and $23 price target. Leerink Swann upgraded the shares of CSII in a report on Monday, August 22 to “Outperform” rating. The rating was downgraded by Bank of America to “Underperform” on Thursday, October 8. The firm earned “Hold” rating on Monday, August 10 by Zacks. As per Thursday, August 4, the company rating was upgraded by Bank of America. The firm has “Sell” rating by Zacks given on Thursday, September 3.
Cardiovascular Systems, Inc., incorporated on December 6, 2000, is a medical technology company. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications. The Company’s peripheral artery disease (PAD) systems are catheter platforms capable of treating a range of plaque types in leg arteries both above and below the knee. The Company’s products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral.
More important recent Cardiovascular Systems Inc (NASDAQ:CSII) news were published by: Fool.com which released: “Why Cardiovascular Systems Inc’s Stock Flatlined Today” on January 23, 2016, also Reuters.com published article titled: “BRIEF-Cardiovascular Systems Inc signs distribution agreement with Medikit…”, Bizjournals.com published: “Former Cardiovascular Systems CEO David Martin dies at 51” on May 05, 2016. More interesting news about Cardiovascular Systems Inc (NASDAQ:CSII) was released by: Prnewswire.com and their article: “Shareholder Class Action Filed Against Cardiovascular Systems, Inc. – CSII” with publication date: February 18, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford